Compare ENTA & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTA | SRTA |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.6M | 388.1M |
| IPO Year | 2012 | N/A |
| Metric | ENTA | SRTA |
|---|---|---|
| Price | $14.23 | $4.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $20.40 | $7.81 |
| AVG Volume (30 Days) | 110.5K | ★ 649.7K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,814,000.00 | N/A |
| Revenue This Year | $7.76 | $39.27 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $4.96 | $3.85 |
| 52 Week High | $17.15 | $6.02 |
| Indicator | ENTA | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 55.91 |
| Support Level | $13.39 | $4.23 |
| Resistance Level | $15.52 | $4.69 |
| Average True Range (ATR) | 0.75 | 0.16 |
| MACD | 0.20 | 0.05 |
| Stochastic Oscillator | 75.80 | 89.57 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.